Wildon Farwell, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 18,285 shares at $25.80 ($472K) on 2024-03-07, disclosed to the SEC on 2024-03-11.
Scheduled sale ($472k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.80 | 8,364 | $216K | 45.7% |
| 2 | $25.80 | 8,364 | $216K | 45.7% |
| 3 | $26.20 | 1,557 | $41K | 8.6% |
| Total | $25.83 avg | 18,285 | $472K | 100% |
| Filing → |
| DYN | SELL | 2024-05-17 | $122K | — | Filing → |
| DYN | SELL | 2024-03-12 | $67K | — | Filing → |
| DYN | SELL | 2024-02-28 | $10K | — | Filing → |